WB result of mTOR Recombinant Rabbit mAb
Primary antibody: mTOR Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: HeLa whole cell lysate 20 μg
Lane 2: MCF7 whole cell lysate 20 μg
Lane 3: A549 whole cell lysate 20 μg
Lane 4: MEF whole cell lysate 20 μg
Lane 5: K-562 whole cell lysate 20 μg
Lane 6: Raji whole cell lysate 20 μg
Lane 7: Hep G2 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 289 kDa
Observed MW: 270 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | mTOR |
| Location | Cytoplasm, Cell membrane, Endoplasmic reticulum membrane, Mitochondrion outer membrane |
| Accession | P42345 |
| Clone Number | S-6467 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB, IHC-P |
| Reactivity | Hu, Ms, Rt, Mk |
| Positive Sample | HeLa, MCF7, A549, MEF, K562, Raji, Hep G2, C2C12, C6, COS-7 |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000-1:5000 | Hu, Ms, Rt |
| IHC-P | 1:500 | Hu, Ms, Rt |
Background
mTOR (mechanistic target of rapamycin) is a serine/threonine protein kinase of 2,549 amino acids (molecular weight ~280 kDa) encoded in the p36.2 region of human chromosome 1, belonging to the phosphatidylinositol 3-kinase-related kinase (PIKK) family; its C-terminus contains a kinase domain and includes regulatory domains such as FAT, FRB, and FATC, while its N-terminus contains approximately 20 HEAT repeats that mediate protein–protein interactions. Within cells, mTOR exists in two structurally and functionally distinct multiprotein complexes: mTORC1 is composed of mTOR, Raptor, mLST8, PRAS40, and Deptor and is sensitive to acute rapamycin treatment; mTORC2 is composed of mTOR, Rictor, mSin1, mLST8, and Protor, among others, and is insensitive to rapamycin. The core function of mTORC1 is to serve as a sensor of nutrient and energy status, integrating signals such as amino acid, growth factor, and ATP levels, and promoting protein synthesis by phosphorylating its key downstream substrates S6K1 and 4E-BP1 while simultaneously inhibiting catabolic processes such as autophagy, thereby maintaining a balance between anabolism and catabolism to regulate cell growth. Abnormal activation of the mTOR signaling pathway is closely associated with the occurrence and development of various tumors, making it an important target for cancer therapy; rapamycin and its analogs allosterically inhibit mTORC1 activity by forming a complex with FKBP12 that binds to the FRB domain.
Picture
Picture
Western Blot
WB result of mTOR Recombinant Rabbit mAb
Primary antibody: mTOR Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: C2C12 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 289 kDa
Observed MW: 270 kDa
WB result of mTOR Recombinant Rabbit mAb
Primary antibody: mTOR Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: C6 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 289 kDa
Observed MW: 270 kDa
WB result of mTOR Recombinant Rabbit mAb
Primary antibody: mTOR Recombinant Rabbit mAb at 1/1000 dilution
Primary antibody incubation conditions: overnight at 4°C
Lane 1: COS-7 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 289 kDa
Observed MW: 270 kDa
Immunohistochemistry
IHC shows positive staining in paraffin-embedded human colon. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human kidney. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human testis. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human colon cancer. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human ovarian cancer. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded mouse brain. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded rat brain. Anti-mTOR antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
